Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lein

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Aktuelle Urologie|July 28, 2009
[New biomarkers and application of multivariate models for detection of prostate cancer]C Stephan, H Cammann, H Rittenhouse, et al.
British Journal of Cancer|June 17, 2010
Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumoursB Nitzsche, C Gloesenkamp, M Schrader, et al.
Aktuelle Urologie|November 4, 2008
[Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options]J Ebbing, F Christoph, C Kempkensteffen, et al.
Der Urologe. Ausg. A|June 12, 2009
[MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?]A Schaefer, M Jung, G Kristiansen, et al.
International Journal of Cancer|January 6, 1997
Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in bloodW Henke, M Jung, K Jung, et al.
Clinical Chemistry|January 6, 2000
Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?K Jung, U Elgeti, M Lein, et al.
Clinical Chemistry|January 6, 2000
Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implicationsK Jung, B Brux, M Lein, et al.
Clinical Chemistry|September 1, 1996
Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cellsW Henke, M Jung, K Jung, et al.
Free Radical Biology & Medicine|January 1, 1997
Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cellsK Jung, B Seidel, B Rudolph, et al.
European Urology|February 15, 2001
Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosisM Lein, K Jung, U Elgeti, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Aktuelle Urologie|July 28, 2009
[New biomarkers and application of multivariate models for detection of prostate cancer]C Stephan, H Cammann, H Rittenhouse, et al.
British Journal of Cancer|June 17, 2010
Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumoursB Nitzsche, C Gloesenkamp, M Schrader, et al.
Aktuelle Urologie|November 4, 2008
[Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options]J Ebbing, F Christoph, C Kempkensteffen, et al.
Der Urologe. Ausg. A|June 12, 2009
[MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?]A Schaefer, M Jung, G Kristiansen, et al.
International Journal of Cancer|January 6, 1997
Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in bloodW Henke, M Jung, K Jung, et al.
Clinical Chemistry|January 6, 2000
Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?K Jung, U Elgeti, M Lein, et al.
Clinical Chemistry|January 6, 2000
Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implicationsK Jung, B Brux, M Lein, et al.
Clinical Chemistry|September 1, 1996
Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cellsW Henke, M Jung, K Jung, et al.
Free Radical Biology & Medicine|January 1, 1997
Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cellsK Jung, B Seidel, B Rudolph, et al.
European Urology|February 15, 2001
Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosisM Lein, K Jung, U Elgeti, et al.
Pageof 11